3Li N,Li S,Yu C,et al.Plasma Lp-PLA2in acute coronary syndrome:association with major adverse cardiac events in a community-based cohort[J].Postgrad Med J,2010,122(4):200-205.
5The Lp-PLA2Studies collaboration.Lipoprotein-associated phosphor-lipase A2and risk of coronary disease,stroke and mortality[J].Lancet,2010,375(9725):1536-1544.
6Packard CJ,O’Reilly DSJ,Caslake MJ,et al.Lipoprotein-associated phospholipase A2as an independent predictor of coronary heart disease[J].N Engl J Med,2000,343(16):1148-1155.
7Casas JP,Ninio E,Panayiotou A,et al.PLA2G7genotype,lipoprotein-associated phospholipase A2activity,and coronary heart diseaserisk in 10494cases and 15624controls of European Ancestry[J].Circulation,2010,121(21):284-293.
9Zahwski A,Macphee c.Role of lipoprotein—associated phospholipase A2in atherosclerosis:biology,epidemiology,and possible therapeutic target[J].Arterioscler Thromb Vase Bid,2005,25(5):923-931.
10Khuseyinova N,Imhof A,Rothenbacher D,et al.Association betwⅢI Lp-PLA2and coronary artery disease:focus on its relationship with lipopmteins and markers of inflammation and hemostasis[J].Atherosclerosis,2005,182(1):181-188.
7Corsetti JP, Rainwater DL, Moss AJ, et al. High lipoprotein- associated phospholipase A2 is a risk factor for recurrent coronary events in postinfarcfion patients. Clin Chem, 2006, 52: 1331- 1338.
8Brilakis ES, McConnell JP, Lennon RJ, et al. Association of lipoprotein-associated phospholipase .A_2 levels with coronary artery disease risk factors, angiographic coronary artery disease, and major adverse events at follow-up. Eur Heart J,2005,26: 137- 144.
9Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies : Part II. Circulation,2003,108 : 1772-1778.
10de Korte CL, Sierevogel MJ, Mastik F, et al. Identification of atherosclerotic plaque components with intravascular ultrasound elastography in vivo: a Yucatan pig study. Circulation, 2002, 105 : 1627-1630.
